Sanofi’s Atopic Dermatitis Drug Fails to Meet Expectations, Boosts Nektar
Thursday witnessed a noticeable shift in the pharmaceutical stock market, as revelations about a recent drug trial had contrasting impacts on the shares of two separate entities, Sanofi and Nektar Therapeutics (NKTR). This change was largely due to the general…
